Seoul National University Hospital;Toolgen Incorporated;Seoul National University R & DB Foundation
发明人:
申请号：
EP17841736.6
公开号：
EP3502261A1
申请日:
2017.08.21
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention relates to artificially engineered angiogenesis-related factors and a use thereof, for angiogenesis regulation. More specifically, the present invention relates to a system that can artificially regulate angiogenesis, including artificially engineered angiogenesis-related factors to regulate angiogenesis and/or a composition capable of artificially engineering angiogenesis-related factors. In specific aspects, the present invention relates to artificially engineered angiogenesis-related factors such as VEGFA, HIF1A, ANGPT2, EPAS1, ANGPTL4, etc. and/or an angiogenesis regulatory system by their expression products thereof.
